Genotropin Preservative Free is a drug owned by Pharmacia And Upjohn Co. It is protected by 4 US drug patents filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Nov 20, 2018. Details of Genotropin Preservative Free's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US6152897 | Syringe |
Nov, 2018
(6 years ago) |
Expired
|
| US5716338 | Dual-chamber type injection cartridge with bypass connection |
Feb, 2015
(9 years ago) |
Expired
|
| US5501673 | Injection cartridge |
Apr, 2013
(11 years ago) |
Expired
|
| US5435076 | Injection device |
Apr, 2013
(11 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Genotropin Preservative Free is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Genotropin Preservative Free's family patents as well as insights into ongoing legal events on those patents.
Genotropin Preservative Free's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Genotropin Preservative Free's generic launch date based on the expiry of its last outstanding patent is estimated to be Nov 20, 2018 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Genotropin Preservative Free Generics:
There are no approved generic versions for Genotropin Preservative Free as of now.
Alternative Brands for Genotropin Preservative Free
There are several other brand drugs using the same active ingredient (Somatropin Recombinant) as Genotropin Preservative Free. Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | |||
|---|---|---|---|---|
| Emd Serono |
| |||
| Genentech |
| |||
| Novo Nordisk Inc |
|
About Genotropin Preservative Free
Genotropin Preservative Free is a drug owned by Pharmacia And Upjohn Co. Genotropin Preservative Free uses Somatropin Recombinant as an active ingredient. Genotropin Preservative Free was launched by Pharmacia And Upjohn in 1996.
Approval Date:
Genotropin Preservative Free was approved by FDA for market use on 23 October, 1996.
Active Ingredient:
Genotropin Preservative Free uses Somatropin Recombinant as the active ingredient. Check out other Drugs and Companies using Somatropin Recombinant ingredient
Dosage:
Genotropin Preservative Free is available in injectable form for injection use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 0.6MG/VIAL | INJECTABLE | Prescription | INJECTION |
| 0.2MG/VIAL | INJECTABLE | Prescription | INJECTION |
| 0.8MG/VIAL | INJECTABLE | Prescription | INJECTION |
| 1MG/VIAL | INJECTABLE | Prescription | INJECTION |
| 1.2MG/VIAL | INJECTABLE | Prescription | INJECTION |
| 0.4MG/VIAL | INJECTABLE | Prescription | INJECTION |
| 1.6MG/VIAL | INJECTABLE | Prescription | INJECTION |
| 1.8MG/VIAL | INJECTABLE | Prescription | INJECTION |
| 2MG/VIAL | INJECTABLE | Prescription | INJECTION |
| 1.4MG/VIAL | INJECTABLE | Prescription | INJECTION |